Pediatr Phys Ther
Antineoplastic AgentsGaitGait Disorders, Neurologic
Dr. Samuel Jacob Milanovich, MD
NPI1669682837PAC ID2264579408
- Part D claims, 2024
- 82
- Publications
- 11
- Clinical trials
- 10
- MIPS score, 2024
- 83
- Hospital affiliations
- 2
- Practice address
- 801 Broadway North, Fargo, ND 58102
- Practice phone
- Call (701) 234-7550
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Sanford Fargo Hospice
Hospice - Hospital-Owned · Fargo, North Dakota
Find Dr. Milanovich's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Samuel Jacob Milanovich is a pediatric hematology and oncology physician in Fargo, North Dakota
Dr. Milanovich practices at Sanford Fargo Hospice in Fargo, North Dakota.
Dr. Milanovich's NPI, 1669682837, was assigned on May 23, 2007. Dr. Milanovich holds North Dakota license PT16066.
NPI and contact details
- NPI
- 1669682837NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2264579408
- NPI enumeration date
- May 23, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (701) 234-7550
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Samuel Jacob Milanovich practices at Sanford Fargo Hospice in Fargo, North Dakota
Dr. Milanovich's primary practice is Sanford Fargo Hospice, at 801 Broadway North, Fargo, ND 58102 in Cass County. The practice phone is (701) 234-7550.
- Sanford Fargo Hospice801 Broadway North, Fargo, ND 58102 · Cass CountyPhone(701) 234-7550
Source: Dmand AI Affiliation Data
Dr. Samuel Jacob Milanovich is affiliated with 3 sites of care and 3 medical groups
Dr. Milanovich's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dr. Milanovich is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Milanovich to 1 more hospital and 2 medical groups, each named with a free account.
Sanford Fargo HospicePrimary
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Samuel Jacob Milanovich's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Milanovich practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Sanford Fargo Hospice | Available with a free account |
| +2 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Milanovich practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Samuel Jacob Milanovich is one of 4 pediatric hematologys and oncology physicians in North Dakota
Pediatric hematology-oncology is Dr. Milanovich's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dmand AI has Dr. Milanovich's licenses on file in 4 states: North Dakota, Pennsylvania, South Dakota and Wisconsin.
Specialties and state licenses
- Pediatric hematology and oncology, North DakotaPrimary
- Pennsylvania license
- Pediatrics, South Dakota
- Wisconsin license
Pediatric hematologys and oncology physicians near Dr. Milanovich
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
4pediatric hematologys and oncology physicians in North Dakota
4pediatric hematologys and oncology physicians in Fargo
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Samuel Jacob Milanovich's patients have a median age of 15
Across all payers, Dmand AI patient panel data puts Dr. Milanovich's median patient age at 15, with 43% women.
Dr. Milanovich's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 15
Patient panel by sex, all payers
- Women43%
- Men57%
Source: Dmand AI Patient Panel Data
Dr. Samuel Jacob Milanovich wrote 82 Medicare Part D claims in 2024
In 2024, Dr. Milanovich wrote 82 Medicare Part D claims. 66% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $152,041 in total drug cost. In 2023, CMS named 35 claims across 2 drugs.
Part D claims, 202482
Drugs named by CMS1
Total drug cost$152,041
Dr. Milanovich's Part D claims by kind of drug, 2024
- Generic54 claims66%
- Brand-name28 claims34%
Dr. Milanovich's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 352024: 1169%
Drugs named by CMS: 1 in 2024, 2 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Samuel Jacob Milanovich scored 83 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Milanovich for performance year 2024, reported as part of a group. Dr. Milanovich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Milanovich's MIPS scores, performance year 2024
- 83of 100Final score
- 71.8of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
- 71of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find pediatric hematologys and oncology physicians like Dr. Milanovich by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Samuel Jacob Milanovich has 11 publications on record
Dmand AI links 11 papers to Dr. Milanovich, published from 2012 to 2024. 2013 was the busiest year, with 2. The most frequent topics are DNA-Binding Proteins, Gene Expression Regulation and Hematopoietic Stem Cells. Dr. Milanovich's most frequent co-authors are Sridhar Rao, MD, PhD, Jeremy Russell Allred, MD and Peter Alexander Argenta, MD.
Papers11
Years published2012 to 2024
Dr. Milanovich's papers by year, 2012 to 2024
Topics Dr. Milanovich writes about most
- DNA-Binding Proteins
- Gene Expression Regulation
- Hematopoietic Stem Cells
Dr. Milanovich's most frequent co-authors
- Sridhar Rao, MD, PhD4 shared papers
- Jeremy Russell Allred, MD1 shared paper
- Peter Alexander Argenta, MD1 shared paper
Recent publications by Dr. Milanovich
J Cell Mol Med
Gene Expression Regulation, NeoplasticOrgan SpecificityRNA-Seq
Stem Cells Transl Med
AdipocytesAdipose TissueMesenchymal Stem Cells
AneuploidyCell Cycle ProteinsCell Proliferation
See who Dr. Milanovich researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Milanovich works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Samuel Jacob Milanovich has worked on 10 clinical trials
Dmand AI links Dr. Milanovich to 10 clinical trials, 6 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Histiocytosis, Langerhans-Cell, Down Syndrome and Ganglioneuroblastoma. National Cancer Institute (NCI) sponsors the most, 6.
Clinical trials with Dr. Milanovich by phase
- NonePhase 1: no trials
- 4Phase 2: 4 trials
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Milanovich's trials
- Histiocytosis, Langerhans-Cell
- Down Syndrome
- Ganglioneuroblastoma
- Glioblastoma
- Leukemia, Biphenotypic, Acute
Investigators on the most trials with Dr. Milanovich
- Erin Kelly Barr, MD7 shared trials
- Kishor Mallikarjun Bhende, MD7 shared trials
- Laura K. Gowans, MD7 shared trials
Recent clinical trials with Dr. Milanovich
A Randomized Phase 3 Trial of Nivolumab (NSC# 748726) in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
NivolumabCyclophosphamideDoxorubicin Hydrochloride
Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial (opens in a new tab)
Active, not recruitingPhase 2
PheochromocytomaHistiocytosis, Langerhans-CellTipifarnib
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma (opens in a new tab)
RecruitingPhase 3
CarboplatinSelumetinib SulfateVincristine Sulfate
Veliparib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Malignant Glioma Without H3 K27M or BRAFV600 Mutations (opens in a new tab)
Active, not recruitingPhase 2
GlioblastomaAstrocytomaTemozolomideVeliparibRadiation Therapy
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) (opens in a new tab)
Active, not recruitingPhase 3
GanglioneuroblastomaNeuroblastomaLorlatinibBusulfanCarboplatin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Samuel Jacob Milanovich received $1,487 in industry payments from 2019 to 2025
CMS Open Payments shows 15 general payments to Dr. Milanovich from 10 drug and device companies from 2019 to 2025. Honoraria make up the largest share, 52% of the total. Pfizer Inc. paid the most, $843.
General payments to Dr. Milanovich by program year, 2019 to 2025
General payments to Dr. Milanovich by kind, 2019 to 2025
$1.5Kin total
- Honoraria$77052%
- Food and beverage$69747%
- Education$201%
Companies that paid Dr. Milanovich the most, 2019 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Samuel Jacob Milanovich's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Samuel Jacob Milanovich
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Samuel Jacob Milanovich's NPI number?
Dr. Samuel Jacob Milanovich's NPI number is 1669682837. It was assigned on May 23, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Samuel Jacob Milanovich?
Dr. Samuel Jacob Milanovich is a pediatric hematology and oncology physician in Fargo, North Dakota. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Samuel Jacob Milanovich practice?
Dr. Milanovich practices at 801 Broadway North, Fargo, ND 58102. Dr. Milanovich's primary practice is Sanford Fargo Hospice in Fargo, North Dakota. Dmand AI also links Dr. Milanovich to 1 hospital and 2 medical groups.
What is Dr. Samuel Jacob Milanovich's office phone number?
The practice phone on file for Dr. Milanovich is (701) 234-7550.
What is Dr. Samuel Jacob Milanovich's medical license number?
Dr. Milanovich holds North Dakota license PT16066, one of the licenses on file in 4 states.
Which states has Dr. Samuel Jacob Milanovich been licensed in?
Dmand AI has state licenses on file for Dr. Milanovich in North Dakota, Pennsylvania, South Dakota and Wisconsin.
Which hospitals is Dr. Samuel Jacob Milanovich affiliated with?
Dr. Milanovich is affiliated with Sanford Broadway Medical Center. Dmand AI links Dr. Milanovich to 1 more hospital.
What medical group is Dr. Samuel Jacob Milanovich part of?
Dr. Milanovich is linked to Sanford West Fargo Clinic. Dmand AI links Dr. Milanovich to 2 more medical groups.
Does Dr. Samuel Jacob Milanovich accept Medicare?
Yes. CMS lists Dr. Milanovich as accepting Medicare assignment.
What is Dr. Samuel Jacob Milanovich's MIPS score?
Dr. Milanovich's MIPS final score for performance year 2024 is 83 out of 100, reported as part of a group.
Show 5 more questionsShow fewer questions
What drugs does Dr. Samuel Jacob Milanovich prescribe most?
In 2024 Medicare Part D data, Dr. Milanovich's most prescribed drugs by claims were Bosulif.
Has Dr. Samuel Jacob Milanovich received payments from drug or device companies?
CMS Open Payments shows $1,487 in general payments to Dr. Milanovich from 10 companies from 2019 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Samuel Jacob Milanovich been practicing?
Dr. Milanovich graduated from medical school in 2006, 20 years ago.
Does Dr. Samuel Jacob Milanovich do research?
Dmand AI links 11 publications to Dr. Milanovich, published from 2012 to 2024. Dr. Milanovich has worked on 10 clinical trials.
Who does Dr. Samuel Jacob Milanovich publish with?
Dr. Milanovich's most frequent co-authors are Sridhar Rao, MD, PhD (4 shared papers), Jeremy Russell Allred, MD (1 shared paper) and Peter Alexander Argenta, MD (1 shared paper).
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in North Dakota by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card